Literature DB >> 17975388

Extracorporeal treatment of intoxications.

Anne-Cornélie J M de Pont1.   

Abstract

PURPOSE OF REVIEW: The purpose of this article is to provide the critical care clinician with a comprehensive review of the indications for extracorporeal elimination of toxic substances, to summarize the different techniques and the intoxications for which these techniques are suitable. RECENT
FINDINGS: In the last year, several excellent reviews about toxicological topics have been published. These reviews focused on intoxications in children, the approach of the patient with an unknown overdose, management of intoxications with salicylates, beta-blockers and calcium antagonists and liver support systems. Important developments include the use of high-flux, high-efficiency membranes and albumin dialysis using the molecular adsorbent recirculating system (MARS). This system offers possibilities for the removal of protein-bound substances such as diltiazem, phenytoin and theophylline.
SUMMARY: Although large randomized controlled trials are scarce in the field of toxicology, the treatment of intoxications is becoming more and more evidence based. This review summarizes the current knowledge and recommendations concerning the extracorporeal treatment of intoxications and discusses new developments in the field, such as the use of high-flux, high-efficiency membranes and albumin dialysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975388     DOI: 10.1097/MCC.0b013e3282f0febd

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  10 in total

1.  Acute liver impairment after sodium valproate overdose.

Authors:  William Stephen Waring; Andrew C Nixon
Journal:  BMJ Case Rep       Date:  2009-05-11

2.  Phenytoin Toxicity Treatment with Haemodialysis in Epilepsy due to Glioblastoma Multiforme: Case Report and Review of the Literature.

Authors:  Karishma Sharma; Aditi Vakil; Ahmed Sokwala; Dilraj Sokhi
Journal:  Case Rep Neurol       Date:  2019-12-10

Review 3.  Management of the critically poisoned patient.

Authors:  Jennifer S Boyle; Laura K Bechtel; Christopher P Holstege
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-06-29       Impact factor: 2.953

4.  Prolonged Refractory Hypotension following Combined Amlodipine and Losartan Ingestion Responsive to Metaraminol.

Authors:  James O M Plumb; Craig Stewart; Michael Eddleston; Thearina de Beer
Journal:  Case Rep Med       Date:  2011-05-12

Review 5.  Management of toxic ingestions with the use of renal replacement therapy.

Authors:  Timothy E Bunchman; Maria E Ferris
Journal:  Pediatr Nephrol       Date:  2010-10-12       Impact factor: 3.714

6.  High-dose continuous venovenous hemofiltration combined with charcoal hemoperfusion for methotrexate removal.

Authors:  Carrie Grafft; Heidi Gunderson; Loralie Langman; Joseph C Farmer; Nelson Leung
Journal:  NDT Plus       Date:  2011-02-24

7.  Extracorporeal treatment in children with acute severe poisoning.

Authors:  Xiaomei Sun; Xiuying Chen; Jing Lu; Yuhong Tao; Lijuan Zhang; Liqun Dong
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

8.  The Efficacy of Albumin Dialysis in the Treatment of Severe Cholestatic Drug-Induced Liver Injury.

Authors:  Mechu Narayanan; Ravi S Vora; Mary M Flynn; Ram M Subramanian
Journal:  Crit Care Explor       Date:  2022-08-11

9.  Hemoperfusion leads to impairment in hemostasis and coagulation process in patients with acute pesticide intoxication.

Authors:  Samel Park; Md-Imtiazul Islam; Ji-Hun Jeong; Nam-Jun Cho; Ho-Yeon Song; Eun-Young Lee; Hyo-Wook Gil
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

10.  Hemoadsorption Improves Survival of Rats Exposed to an Acutely Lethal Dose of Aflatoxin B1.

Authors:  Karl-Gustav Ruggeberg; Pamela O'Sullivan; Timothy J Kovacs; Kathryn Dawson; Vincent J Capponi; Phillip P Chan; Thomas D Golobish; Maryann C Gruda
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.